Open AccessHER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy
Author(s) -
Jiadi Gan,
Yuqiang Huang,
Jun Liao,
Liangyue Pang,
Wenfeng Fang
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s335217
Subject(s) - afatinib , medicine , osimertinib , gefitinib , oncology , lung cancer , cohort , erlotinib , cancer , epidermal growth factor receptor